Tag: molecular diagnostics

December 6, 2018

Myriad Validates Polygenic Score to Predict Breast Cancer Risk

Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the...
May 8, 2018

Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results

Myriad Genetics (NASDAQ:MYGN), a global leader in molecular diagnostics and personalized medicine, today announced financial results for its fiscal third-quarter...
May 7, 2018

HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology

HTG Molecular Diagnostics (NASDAQ:HTGM) a provider of instruments, reagents and services for molecular profiling applications, and Firalis S.A., a provider of...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 13, 2018

Olerup QTYPE® Receives CE Mark Certification

CareDx (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for...
April 10, 2018

CareDx Launches HeartCare for Heart Transplant Recipients

CareDx (NASDAQ:CDNA), a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for...
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.